EATG » Access

Access

Generic HIV medicines: boon or bust?

The advent of generic HIV medications in the 2000s had a dramatic effect on improving outcomes in developing countries with a high HIV/AIDS burden. Before that, death rates were skyrocketing…

Antiretroviral shortage reaches 100% in Venezuela

Every day, the media throughout Latin America show news about the situation in Venezuela, unsustainable wherever you look, and that affects the health and lives of thousands of people, including…

Argentine NGO objects to antiretroviral patent request

--NGO requests rejection of Gilead Sciences patent request for AIDS drug --It alleges it would increase costs, says there is no basis for request --About half of those infected with…

MSF welcomes Members of the European Parliament response to the US pharmaceutical pressure to stop EU action on high drug prices

6 March 2018 — The Pharmaceutical Research and Manufacturers of America (PhRMA) and the Biotechnology Innovation Organization (BIO), two US pharmaceutical lobby groups, have requested the US Trade Representative (USTR)…

Pharmaceutical companies and non-profits team up to provide affordable hepatitis C treatment in Latin America

Buenos Aires, Geneva, 5 March 2018 -- A new collaboration between pharmaceutical companies and non-profit organizations will manufacture and supply a new, more affordable, hepatitis C treatment regimen in Latin…

Study: TRIPS flexibilities widely used by countries, contrary to reports

Despite the widespread view that the flexibilities included in international trade rules are not often used, a new study found that countries make extensive use of those flexibilities. The study…

HIV prevention: It’s time to stop accepting the status quo, PrEP Summit concludes

The biggest barrier to HIV pre-exposure prophylaxis (PrEP) becoming more available and more widely used is not cost so much as widespread acceptance of the status quo in HIV prevention,…

HIV i-Base: HIV Treatment Bulletin, 23 February 2018

HIV Treatment Bulletin (HTB) is a community publication produced by HIV i-Base. The fourth issue of HTB for 2018 is now out. It features highlights from the preliminary programme of…

Gilead wins Sovaldi domain dispute over Buyers’ club generic sellers

Pharmaceutical company Gilead has made headlines in recent years for offering an effective hepatitis C drug that has helped many patients. And for the fact that it came with an…

Presentations from the PrEP Summit now online

Organised jointly by EATG, AVAC, AIDSfonds, AIDES, AIDS Action Europe, NAM-AIDSMAP, NAT, Prepster, UNAIDS, WHO, the European PrEP Summit was organised in Amsterdam on 9-10 February 2018. The more than…

1 2 3 32